These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Development and specific induction of apoptosis of cultured cell models overexpressing human tau during neural differentiation: Implication in Alzheimer's disease. Tsukane M; Yoshizaki C; Yamauchi T Anal Biochem; 2007 Jan; 360(1):114-22. PubMed ID: 17113559 [TBL] [Abstract][Full Text] [Related]
45. Cholinergic central system, Alzheimer's disease, and anesthetics liaison: a vicious circle? Schifilliti D; Santamaria LB; Rosa G; Di Nino G; Mandal PK; Fodale V J Alzheimers Dis; 2010; 22 Suppl 3():35-41. PubMed ID: 20858949 [TBL] [Abstract][Full Text] [Related]
46. A new tool in the battle against Alzheimer's disease and aging: ex vivo gene therapy. Ebert AD; Svendsen CN Rejuvenation Res; 2005; 8(3):131-4. PubMed ID: 16144466 [TBL] [Abstract][Full Text] [Related]
47. [Recent topics on Alzheimer's disease. Nerve growth factors and Alzheimer's disease]. Tomonaga M Nihon Rinsho; 1988 Jul; 46(7):1600-6. PubMed ID: 3221467 [No Abstract] [Full Text] [Related]
48. The putative neurodegenerative links between depression and Alzheimer's disease. Wuwongse S; Chang RC; Law AC Prog Neurobiol; 2010 Aug; 91(4):362-75. PubMed ID: 20441786 [TBL] [Abstract][Full Text] [Related]
49. Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy. Pramanik S; Sulistio YA; Heese K Mol Neurobiol; 2017 Nov; 54(9):7401-7459. PubMed ID: 27815842 [TBL] [Abstract][Full Text] [Related]
51. Neurotrophic strategies for treating Alzheimer's disease: lessons from basic neurobiology and animal models. Koliatsos VE; Price DL; Clatterbuck RE; Markowska AL; Olton DS; Wilcox BJ Ann N Y Acad Sci; 1993 Sep; 695():292-9. PubMed ID: 8239298 [TBL] [Abstract][Full Text] [Related]
52. Metabolic alterations common to neural and non-neural cells in Alzheimer's disease. Blass JP Hippocampus; 1993; 3 Spec No():45-53. PubMed ID: 8287111 [No Abstract] [Full Text] [Related]
53. Nerve growth factor in Alzheimer's disease: to treat or not to treat? Mobley WC Neurobiol Aging; 1989; 10(5):578-80; discussion 588-90. PubMed ID: 2812231 [TBL] [Abstract][Full Text] [Related]
54. Cytoskeleton and NGF in the pathogenesis and treatment of Alzheimer's disease. Shelanski ML Neurobiol Aging; 1989; 10(5):577; discussion 588-90. PubMed ID: 2812230 [TBL] [Abstract][Full Text] [Related]
55. When parsimony backfires: neglecting DNA repair may doom neurons in Alzheimer's disease. Nouspikel T; Hanawalt PC Bioessays; 2003 Feb; 25(2):168-73. PubMed ID: 12539243 [TBL] [Abstract][Full Text] [Related]
56. [Frontiers of research: Alzheimer's disease]. Lennholm B Lakartidningen; 1987 May; 84(19):1645-54. PubMed ID: 3613764 [No Abstract] [Full Text] [Related]
57. Innervation of cerebral blood vessels: morphology, plasticity, age-related, and Alzheimer's disease-related neurodegeneration. Bleys RL; Cowen T Microsc Res Tech; 2001 Apr; 53(2):106-18. PubMed ID: 11301486 [TBL] [Abstract][Full Text] [Related]
58. The Emerging Therapeutic Role of NGF in Alzheimer's Disease. Xu CJ; Wang JL; Jin WL Neurochem Res; 2016 Jun; 41(6):1211-8. PubMed ID: 26801170 [TBL] [Abstract][Full Text] [Related]
59. Cytokine/neurotrophin interaction in the aged central nervous system. Macdonald NJ; Decorti F; Pappas TC; Taglialatela G J Anat; 2000 Nov; 197 Pt 4(Pt 4):543-51. PubMed ID: 11197527 [TBL] [Abstract][Full Text] [Related]
60. NGF level of is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer's disease. Murase K; Nabeshima T; Robitaille Y; Quirion R; Ogawa M; Hayashi K Biochem Biophys Res Commun; 1993 May; 193(1):198-203. PubMed ID: 8503908 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]